Study of the course of high eosinophil blood disease
Part of Blood & lymphatic clinical trials.
This study follows people with long-term high eosinophils (a type of white blood cell) and related conditions to learn how the illness changes over time. It helps doctors understand patterns of organ involvement and outcomes, which may improve future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with high eosinophils or an eosinophil-related syndrome (HES) or related organ disease
- Your eosinophil count is above 1500 per cubic millimeter, or you have organ damage linked to eosinophils
- Your HES diagnosis started on or after January 1, 2005
- You have health insurance (are “socially insured”)
- You can understand the study information and give consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows families with a genetic condition that causes high levels of white blood cells called eosinophils. Researchers want to understand how the disease develops and changes over time to help predict who may get worse and how to treat it better.
This research study examines how eosinophils (a type of white blood cell) behave and function when they become abnormally high in the blood or tissues. Researchers want to understand these conditions better to potentially improve treatment options.
This trial tests if dupilumab, added to your current treatment, can help with remaining symptoms of hypereosinophilic syndrome (HES) like asthma, eczema, nasal polyps, or eosinophilic esophagitis. You may qualify if you're already on a biologic therapy that lowers eosinophils but still have bothersome symptoms.
This study looks at how the immune system and the esophageal barrier function in people with eosinophilic esophagitis (EoE) compared to those without. It involves taking biopsies during an upper endoscopy to understand the disease better. The results may help improve treatments for EoE.
This study looks at a type of white blood cell called eosinophils in people with interstitial lung disease (a group of conditions that cause lung scarring). It aims to understand if eosinophil levels are linked to the disease, which might help improve future treatments.
This trial tests an intervention meant to improve how well adults with eosinophilic esophagitis (EoE) follow their ongoing treatment plan. It may help you stay on your medicine and get better symptom control by making adherence easier.
Hear when a new Eosinophilia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.